DMD and Duchenne muscular dystrophy: The systemic administration of the AAV6-encoded micro-dystrophin gene not only stabilizes skeletal myofibers but also halts CRISPR component loss, consequently allowing for persistent gene correction and ensuring lifelong skeletal dystrophin expression in DMD mdx4Cv mice [129].